Benjamin Woodman

Suberoylanilide hydroxamic acid, a histone deacetylase inhibitor, ameliorates motor deficits in a mouse model of Huntington's disease

Emma Hockly, Victoria M. Richon, Benjamin Woodman et al. · Proceedings of the National Academy of Sciences · 2003 · 836 citations · Full text

Environmental enrichment slows disease progression in R6/2 Huntington's disease mice

Emma Hockly, Patricia M. Cordery, Benjamin Woodman et al. · Annals of Neurology · 2002 · 331 citations

Genetics, Neurochemical Biomarkers, Environmental Enrichment +16

Impaired Glutamate Uptake in the R6 Huntington's Disease Transgenic Mice

Jean-Charles Liévens, Benjamin Woodman, A. Mahal et al. · Neurobiology of Disease · 2001 · 296 citations · Full text

Genetics, Impaired Glutamate Uptake, Degenerative Pathology +6

Minocycline and doxycycline are not beneficial in a model of Huntington's disease

Donna L. Smith, Benjamin Woodman, Amarbirpal Mahal et al. · Annals of Neurology · 2003 · 169 citations

Standardization and statistical approaches to therapeutic trials in the R6/2 mouse

Emma Hockly, Benjamin Woodman, Amarbirpal Mahal et al. · Brain Research Bulletin · 2003 · 137 citations

Knockout Mouse, Preclinical Drug Evaluation, Statistical Approaches +11